Relmada Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:RLMD) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 118.19 M223.33 M152.91 M97.55 M45.82 M94 M 총 부채 12.6 M15.06 M12.47 M12.19 M10.3 M7.49 M 자본금 총액 105.58 M208.26 M140.44 M85.36 M35.52 M86.51 M 총 부채 및 주주자본 118.19 M223.33 M152.91 M97.55 M45.82 M94 M 총부채 —————— 순부채 ——————

뉴스

Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call Transcript

Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?

Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call Transcript

미주호, 렐마다 암 치료 데이터 긍정적...투자의견 ’매수’ 유지

Mizuho reiterates Relmada stock rating on positive cancer trial data

RLMD Stock Surges 42% in a Week: Here's What You Should Know

Avago, Lumentum among market cap stock movers on Monday

Tesla and Facebook among market cap stock movers on Monday

미주호, 방광암 임상 데이터에 렐마다 주식 등급 재확인

Mizuho reiterates Relmada stock rating on bladder cancer trial data

Hims & Hers 주가 장전 급등, 화이자와 Agilent Technologies 하락